Sage Integrative Health • Alexander Shulgin Research Institute • Berkeley Center for the Science of Psychedelics (BCSP)
Operations Manager • Psychiatry position • Development Director
Locations
Showing 1137 Locations-
-
ATAI Life Sciences • Introspect • Psychedelic Society Berlin • PsychonautWiki • Viridia Life Science • Charite University, Berlin, Germany • MIND Foundation • Empath Bio • OVID Health Systems • German Federal Ministry of Education and Research
ATAI Life Sciences AG • Masawa Management • Berggruen Holdings
Florian Brand • Simon Seibold • Joshua Haynes
Internship - Business Operations • Business Operations & Strategy Manager (m/w/d) • Business Operations Intern • Business Associate • Working Student - Business Operations • Head of Investment (m/w/d) • Business Operations & Strategy Manager (m/w/d) • VP Human Resources/People • VP of Investment
Ketamine-Induced Brain Changes and Their Modulation by Lamotrigine • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. • Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
-
A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects • A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects • A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects • Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
-
Psychedelic Society Switzerland • Schweizerischer Nationalfonds • University of Bern
Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
-
Besançon, Bourgogne-Franche-Comté, France
The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression
-
National Institute on Drug Abuse (NIDA) • National Institute of Neurological Disorders and Stroke (NINDS) • National Institutes of Health Clinical Center (CC) • National Institute on Minority Health and Health Disparities (NIMHD) • National Institutes of Health (NIH) • National Institute of Mental Health (NIMH) • National Cancer Institute (NCI) • National Institute of General Medical Sciences (NIGMS) • National Institute of Nursing Research (NINR) • Mid-Atlantic Epilepsy and Sleep Center, LLC • National Center for Research Resources (NCRR) • National Institute on Deafness and Other Communication Disorders (NIDCD) • National Institute on Aging (NIA) • Walter Reed National Military Medical Center
Evaluating Ketamine and Psychological Sequelae • Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain • A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue • Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder • Mechanism of Action Underlying Ketamine s Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression • Effect of Ketamine on Fatigue Following Cancer Therapy • Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus • Rapid Antidepressant Effects of Ketamine in Major Depression • Neurobiology of Suicide
-
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
-
Beverly Hills, California, USA
Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia
-
Biberist, Solothurn, Switzerland
Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
-
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
-
Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
-
University of Alabama at Birmingham
Psilocybin-facilitated Treatment for Cocaine Use • Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures • A Study to Evaluate Ketamine for the Treatment of Rett Syndrome • Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea • Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus • A Study of Ketamine in Patients With Treatment-resistant Depression • miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome • Treatment of Suicidal Ideation With Intravenous Ketamine Infusion • Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery • Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression • Sequential Therapy for the Treatment of Severe Bipolar Depression. • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
-
Birmingham, England, United Kingdom
Psychedelic Society of Birmingham
-
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
-
Neuma Coaching
-
Virginia Polytechnic Institute and State University
-
Indiana University
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
-
HealthPartners Institute
-
Blumenau, Santa Catarina, Brazil
Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression
-
Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain
-
Bobigny, Île-de-France, France
Ketamine Versus Etomidate During Rapid Sequence Intubation: Consequences on Hospital Morbidity
-
Böblingen, Baden-Württemberg, Germany
Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
-
Psybio Therapeutics • Florida Atlantic University
Robert Streisfeld • Scott Fisher
-
Bologna, Emilia-Romagna, Italy
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi • University of Bologna
Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome • Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
-
Bolton, England, United Kingdom
Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
-
Bonn, North Rhine-Westphalia, Germany
University of Bonn
Effects of Ketamine on Eye Movements, Perception and Brain Function
-
Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
-
Bordeaux, Nouvelle-Aquitaine, France
University Hospital, Bordeaux • Institut Bergonié
Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia • Administration of Ketamine to Prevent the Post-operative Pain • Polyamine-free Diet to Prevent Post Surgery Hyperalgesia
-
Eleos • Center for the Neuroscience of Psychedelics • Adelia Therapeutics • Vicente Sederberg • Brigham and Women's Hospital • Boston University • Harvard Medical School • Boston Children's Hospital • Invicro • Massachusetts General Hospital • Beth Israel Deaconess Medical Center • Beth Israel Medical Center • Massachusetts Eye and Ear Infirmary • Tufts Medical Center • Concert Pharmaceuticals • Psy Therapeutics • Hyka Therapeutics
MAZAKALI • Psilos Group
Bob Peatman • Stephen Krupa • Joseph Tucker • Doug Drysdale • Adam Von Reyn
Program Manager - Center for Neuroscience of Psychedelics • Director Quality Assurance Regulatory Affairs • Director Clinical Operations • Director, Clinical Operations • Formulation/Analytical Chemist • Director, Quality Assurance
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD • EEG Studies of Ketamine General Anesthesia • Ketamine for Depression: An MRI Study • Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects • A Study to Evaluate Ketamine for the Treatment of Rett Syndrome • Ketamine Infusion for Treatment-resistant Major Depressive Disorder • Immunomodulatory Properties of Ketamine in Sepsis • A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) • Prevention of Post Mastectomy With Intraoperative Ketamine • The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures • Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder • Effect of Ketamine on Opioid-Induced Hyperalgesia • Efficacy Study of Ketamine for Postoperative Pain in Opioid Dependent Patients • Ketamine for Major Depressive Disorder • The Impact of Ketamine on the Reward Circuitry of Suicidal Patients • Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) • Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy • Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder • Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients • N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression • EEG Studies of Sevoflurane-Induced General Anesthesia • Avoiding Neuromuscular Blockers to Reduce Complications • Prevention of Phantom Limb Pain After Transtibial Amputation • The PATHFINDER Study: A Feasibility Trial • EEG Monitoring in the Emergency Department • Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor • The Effect of Sodium Oxybate on Sleep Architecture • Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia
-
Alder Biopharmaceuticals, Inc.
-
Naropa University • Medicinal Mindfulness • The Awake Network • Magic Agency • Gaia • Psychedelic Club • Integrative Psychiatry Institute
Larry Norder
Study Coordinator
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD • Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers • Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • An Open Label Study of FT218 in Subjects With Narcolepsy • A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
-
Boulogne-Billancourt, Île-de-France, France
Hospital Ambroise Paré Paris
-
Bourgogne-Franche-Comté, France
Centre Hospitalier Universitaire de Besancon
-
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy • Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia • Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.
-
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
-
Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression
-
Conselho Nacional de Desenvolvimento Científico e Tecnológico
-
Slovak psychedelic society - SAPAS
-
Centro Medico Campinas • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
-
Breda, North Brabant, Netherlands
Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
-
Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
-
Brentford, England, United Kingdom
GlaxoSmithKline
-
Foundations Recovery Network • American College of Neuropsychopharmacology
-
KWCG Psychedelic Society
-
Brisbane, Queensland, Australia
Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
-
Bristol, England, United Kingdom
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression • Bristol Imperial MDMA in Alcoholism Study
-
Medcan Biotechnologies • Optimi Health • HealthTech Connex • Albert Labs
-
Brno University Hospital
-
Intranasal Ketamine for Suicidal Ideation in Veterans • Intranasal Ketamine For Pain Control In Patients With Sickle Cell Disease And Vaso-occlusive Episode (VOE) In The PED • A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • An Open Label Study of FT218 in Subjects With Narcolepsy • A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy